Treatment Notes

For patients with renal insufficiency where aminoglycosides are not desired, a beta-lactam may be combined with a fluoroquinolone only IF 2 agents are needed.

Two beta-lactam agents should not be used concurrently (e.g. Pip/Tazo/Cefepime/Meropenem).

See section on double-coverage of gram-negative infections.

Potential sources (e.g. pneumonia, peritonitis, central venous catheters) must be considered when selecting therapy.

Broad-spectrum empiric therapy is ONLY appropriate while cultures are pending i.e. first 48-72 hours.

Antibiotic regimen should be evaluated daily and regimen should be streamlined based on culture data.